Aster Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$10.1K Buy
282
+138
+96% +$4.85K ﹤0.01% 780
2026
Q2
$4.52K Sell
144
-16
-10% -$675 ﹤0.01% 733
2026
Q1
$3.42K Buy
+160
New +$7.62K ﹤0.01% 715
2025
Q3
– Sell
-193
Closed -$4.93K – 1264
2025
Q2
$4.93K Buy
+193
New +$4.21K ﹤0.01% 867
2025
Q1
– Sell
-198
Closed -$4.16K – 1575
2024
Q4
$4.16K Buy
+198
New +$4.58K ﹤0.01% 887

Other funds holding PAHC

Aster Capital Management's PAHC Position: Q3 2026 in Review

Aster Capital Management increased its Phibro Animal Health (PAHC) stake by 96% in Q3 2026, buying an estimated $4.85K and bringing the position to 282 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #780.

Aster Capital Management first reported a position in PAHC in Q4 2024 and has held it in 5 quarters since. 181 funds tracked by Wall St. Rank hold PAHC as of Q3 2026.

  • Aster Capital Management held 282 shares of Phibro Animal Health worth $10.1K as of Q3 2026.
  • Aster Capital Management bought 138 Phibro Animal Health shares in Q3 2026, an estimated $4.85K.
  • Phibro Animal Health made up ﹤0.01% of Aster Capital Management's portfolio in Q3 2026, its #780 holding.
  • Aster Capital Management first reported a position in Phibro Animal Health in Q4 2024 and has held it in 5 quarters since.
  • 181 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2026.

Based on Aster Capital Management's 13F filing for Q3 2026, filed 12 Nov 2026.